These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6167549)

  • 41. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
    J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines.
    Ennis FA; Rook AH; Qi YH; Schild GC; Riley D; Pratt R; Potter CW
    Lancet; 1981 Oct; 2(8252):887-91. PubMed ID: 6117682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells.
    McMichael AJ; Gotch FM; Hildreth JE
    Eur J Immunol; 1982 Dec; 12(12):1002-5. PubMed ID: 6984389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.
    Tsang KY; Zaremba S; Nieroda CA; Zhu MZ; Hamilton JM; Schlom J
    J Natl Cancer Inst; 1995 Jul; 87(13):982-90. PubMed ID: 7629885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.
    McMichael AJ; Gotch FM; Rothbard J
    J Exp Med; 1986 Nov; 164(5):1397-406. PubMed ID: 2430041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures.
    Breuning MH; Breur BS; Engelsma MY; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity.
    Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH
    J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specificity of peptide binding by the HLA-A2.1 molecule.
    Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE
    J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.
    Bernhard H; Jäger E; Maeurer MJ; Meyer zum Büschenfelde KH; Knuth A
    Tissue Antigens; 1996 Jul; 48(1):22-31. PubMed ID: 8864171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides.
    Martinon F; Gomard E; Hannoun C; Lévy JP
    Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
    Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Definition of four HLA-A2 subtypes by CML typing and biochemical analysis.
    van der Poel JJ; Mölders H; Thompson A; Ploegh HL
    Immunogenetics; 1983; 17(6):609-21. PubMed ID: 6407985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.
    Wedemeyer H; Mizukoshi E; Davis AR; Bennink JR; Rehermann B
    J Virol; 2001 Dec; 75(23):11392-400. PubMed ID: 11689620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.
    Ezquerra A; Doménech N; van der Poel J; Strominger JL; Vega MA; López de Castro JA
    J Immunol; 1986 Sep; 137(5):1642-9. PubMed ID: 3489037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recognition of distinct epitopes on the HLA-A2 antigen by cytotoxic T lymphocytes.
    van der Poel JJ; Pool J; Goulmy E; Giphart MJ; van Rood JJ
    Hum Immunol; 1986 Jul; 16(3):247-58. PubMed ID: 2424874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
    Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH
    J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.